Ali Motazedian

702 citations
12 papers · 313 indexed · h-index 11
Topics
Pluripotent Stem Cells Research (4 papers)Renal and related cancers (3 papers)Zebrafish Biomedical Research Applications (3 papers)
Partner nations
AustraliaCanadaJapan

In The Last Decade

Ali Motazedian

12 papers receiving 312 citations

Peers

Ali Motazedian
Comparison fields: 5 of 53
  • Molecular Biology 234
  • Biomedical Engineering 83
  • Surgery 59
  • Oncology 56
  • Pulmonary and Respiratory Medicine 42
Replace Yongli Shan with:
Yongli Shan China
Cixian Bai China
Adam Khalil United States
Anton Wohl Israel
Dejin Zheng China
Karen Dyer Montgomery United States
Frida Holm Sweden
Sebastian Brennig Germany
Rosaria Tinnirello Italy
Eirik Sundlisæter Norway
Ali Motazedian relative to Yongli Shan China Yongli Shan's profile →
Citations per field
00.5×1.5×2.2×
Yongli Shan · 1×
Citations per year

Countries citing papers authored by Ali Motazedian

Since Specialization
Citations

This map shows the geographic impact of Ali Motazedian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Motazedian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Motazedian more than expected).

Fields of papers citing papers by Ali Motazedian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Motazedian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Motazedian. The network helps show where Ali Motazedian may publish in the future.

Co-authorship network of co-authors of Ali Motazedian

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Motazedian. A scholar is included among the top collaborators of Ali Motazedian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Motazedian. Ali Motazedian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 19
3 35
4 14
5 15
6 12
7 17
8 109
9 10
10 22
11 13
12 46

About Ali Motazedian

Ali Motazedian is a scholar working on Developmental Neuroscience, Cell Biology and Biophysics, having authored 12 papers that have together received 313 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (4 papers), Renal and related cancers (3 papers) and Zebrafish Biomedical Research Applications (3 papers). The work is most often cited by research in Molecular Biology (234 citations), Developmental Neuroscience (11 citations) and Cell Biology (34 citations). Ali Motazedian has collaborated with scholars based in Australia, Canada and Japan. Frequent co-authors include Edouard G. Stanley, Santhosh V. Kumar, Amranul Haque, Alicia Oshlack, Alexander N. Combes, Irene M. Ghobrial, Andrew G. Elefanty, Kynan T. Lawlor, Melissa H. Little and Pei Xuan Er. Their work appears in journals such as Nature Communications, PLoS ONE and Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026